In a groundbreaking study published in Pediatric Research, a team of Japanese investigators has provided pivotal insights into the postnatal growth patterns of a highly vulnerable population: very preterm infants born appropriate for gestational age (AGA). This research meticulously tracks the developmental trajectories of these infants from term-equivalent age up to six years, shedding new light on how early birth influences childhood growth and potentially long-term health outcomes. Such comprehensive longitudinal data are both scarce and essential in refining neonatal care strategies and optimizing growth monitoring protocols.
The researchers’ focus on very preterm AGA infants—those born at less than 32 weeks gestation but with birth weights appropriate for their gestational age—addresses a nuanced subgroup within preterm neonates. While small for gestational age (SGA) infants have been extensively studied due to their higher risks of growth impairments, AGA infants born preterm have historically received comparatively less scrutiny. However, these infants remain at substantial risk for various complications influencing their growth trajectories, including metabolic, cardiovascular, and neurodevelopmental disorders in later life. The study underscores the necessity of tailored growth assessments in these patients, rather than relying solely on generalized growth charts.
To construct a detailed picture of growth progression, Moriichi et al. conducted serial assessments of growth parameters including weight, length, and body mass index (BMI) of a cohort of very preterm AGA infants. Starting at the term-equivalent age—around 40 weeks postmenstrual age—the infants’ anthropometric data were followed longitudinally at multiple checkpoints until reaching six years of corrected age. This methodical approach allowed for the identification of unique growth patterns rather than a simple cross-sectional snapshot, highlighting both periods of growth acceleration and potential lags.
One of the most striking findings reported in the study is the heterogeneity of postnatal growth trajectories among these infants. Contrary to the widely held assumption that preterm AGA infants would ‘catch up’ to their full-term peers by early childhood, the analysis reveals that many infants experience prolonged growth delays, particularly in linear growth (length). By six years, a significant proportion of the cohort still demonstrated lower height-for-age z-scores compared to standardized reference populations, indicative of persistent growth deficits. This challenges previously optimistic outlooks and suggests the need for ongoing monitoring beyond the neonatal period.
The researchers employed advanced statistical modeling techniques, including latent class growth analysis, to categorize the cohort into distinct growth trajectory groups. This innovative approach elucidated subpopulations with divergent growth patterns: some with rapid catch-up growth, others with steady but suboptimal increases, and a group exhibiting growth faltering despite being born AGA. The differentiation between these trajectories is clinically crucial, as it informs risk stratification and individualized intervention planning aimed at improving developmental outcomes.
Another significant contribution of the study is the exploration of factors correlating with suboptimal growth. The analysis points to perinatal variables such as respiratory complications, nutritional insufficiencies during hospitalization, and morbidities like bronchopulmonary dysplasia as influential determinants of long-term growth retardation. This emphasizes the interplay between early neonatal morbidity and subsequent growth patterns and advocates for multidisciplinary strategies addressing both acute care and nutritional support in neonatal intensive care units (NICUs).
Nutritional management emerges as a recurring theme in interpreting growth outcomes. The data suggest that achieving optimal weight gain in the immediate postnatal period does not invariably guarantee adequate linear growth or overall health benefits. Rather, a nuanced approach balancing caloric intake, macro- and micronutrient composition, and feeding practices is necessary. Moreover, the authors propose that standard growth charts may not fully capture the growth potential or risks in very preterm AGA infants, advocating for the development or adaptation of growth monitoring tools better suited to this demographic.
Importantly, the study extends its relevance beyond anthropometric measurements by considering the implications of growth trajectories on neurodevelopmental and metabolic health. Although this investigation primarily centers on physical growth, the authors reference accumulating evidence linking early growth failure or rapid ‘catch-up’ phases with increased susceptibility to metabolic syndrome, insulin resistance, and cardiovascular morbidity later in life. Therefore, longitudinal growth monitoring functions not only as a biomarker of physical health but also as a window into broader physiological programming.
The authors also touch upon the challenges clinicians face in balancing growth promotion with the avoidance of adverse sequelae such as adiposity rebound and metabolic disturbances. Their findings support a paradigm shift from simply pursuing rapid catch-up growth towards a more balanced trajectory that fosters both healthy body composition and neurodevelopmental progress. This approach requires robust clinical guidelines and further research into the biological mechanisms governing growth regulation post-prematurity.
From a methodological perspective, the study stands out due to its large sample size, rigorous longitudinal design, and detailed phenotype characterization. The inclusion of serial assessments up to six years empowers healthcare providers to contextualize early growth patterns within a broader developmental framework. The research team’s commitment to high-quality data collection and analysis enhances the reliability of the findings, setting a new standard for future investigations aiming to unravel the complexities of postnatal growth in vulnerable pediatric populations.
This work carries profound implications for clinical practice, particularly within neonatal and pediatric endocrinology spheres. Neonatologists and pediatricians must remain vigilant in monitoring growth beyond hospital discharge, tailoring interventions as needed to mitigate long-term morbidities. Moreover, the findings underline the importance of parental education and support systems to ensure adherence to nutritional and developmental follow-up protocols, ultimately fostering better health trajectories.
In public health contexts, the research highlights the necessity of structured surveillance systems for preterm populations extending through early childhood. Given that preterm birth rates continue to be significant globally, scaling such monitoring frameworks could markedly influence outcomes at a population level. Additionally, policy implications include advocating for enhanced resources for post-discharge care and interdisciplinary coordination among healthcare providers.
Technological advancements could further augment growth monitoring efforts. Integration of electronic health records, growth tracking applications, and telemedicine follow-ups may facilitate more timely identification of growth deviations and prompt interventions. The study implicitly promotes these innovations by establishing a clear need for longitudinal and nuanced data capture in clinical settings.
The knowledge generated by Moriichi and colleagues also sets the stage for future research directions. Longitudinal studies extending into adolescence and adulthood are warranted to fully unravel the lifelong consequences of early growth alterations. Moreover, mechanistic studies investigating the molecular, hormonal, and epigenetic underpinnings of growth variability in preterm infants would deepen understanding and open avenues for targeted therapies.
In conclusion, the landmark study on postnatal growth trajectories of very preterm AGA infants published in Pediatric Research paves the way for more nuanced clinical management and research paradigms. By firmly establishing that growth trajectories are heterogeneous and that many infants experience persistent deficits well into childhood, this research challenges conventional wisdom and underscores the need for personalized care approaches. The integration of these findings into practice could significantly enhance the health and quality of life for a widely underserved patient population.
As the science of neonatal growth advances, studies like this serve as critical reminders of the complexity underlying physical development in early life stages. They emphasize that interventions must extend beyond the neonatal intensive care unit and continue through childhood with a vigilant and informed eye, striving not simply for survival but for thriving among preterm infants who often face myriad challenges. The work done here stands as a beacon guiding clinicians and scientists alike toward better futures for these small yet resilient children.
Subject of Research: Postnatal growth trajectories of very preterm appropriate-for-gestational-age infants
Article Title: Postnatal growth trajectories of very preterm appropriate-for-gestational-age infants from term-equivalent age to 6 years
Article References:
Moriichi, A., Kono, Y., Toyoshima, K. et al. Postnatal growth trajectories of very preterm appropriate-for-gestational-age infants from term-equivalent age to 6 years. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04862-3
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41390-026-04862-3
Keywords: preterm infants, appropriate for gestational age, postnatal growth, growth trajectories, longitudinal study, neonatal morbidity, growth monitoring, pediatric growth, very preterm, term-equivalent age, early childhood development
